Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis

Pedro A. Villablanca, Wilman Olmedo, Michael Weinreich, Tanush Gupta, Divyanshu Mohananey, Felipe N. Albuquerque, Ibrahim Kassas, David Briceño, Cristina Sanina, Thomas A. Brevik, Emily Ong, Harish Ramakrishna, Michael Attubato, Mark Menegus, Jose Wiley, Ankur Kalra

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

BACKGROUND: Studies have shown that chronic total occlusion (CTO) in a noninfarct-related artery in patients with ST-segment-elevation myocardial infarction is linked to increased mortality. It remains unclear whether staged revascularization of a noninfarct-related artery CTO in patients with ST-segment-elevation myocardial infarction translates to improved outcomes. We performed a meta-analysis to compare outcomes between patients presenting with ST-segment-elevation myocardial infarction with concurrent CTO who underwent percutaneous coronary intervention of noninfarct-related artery CTO versus those who did not. METHOD AND RESULTS: We conducted an electronic database search of all published data. The primary end point was major adverse cardiovascular events. Secondary end points were all-cause mortality, cardiovascular mortality, myocardial infarction, repeat revascularization with either percutaneous coronary intervention or coronary artery bypass grafting, stroke, and heart failure readmission. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed. Random effects model was used and heterogeneity was considered if I2 >25. Six studies (n=1253 patients) were included in the analysis. There was a significant difference in major adverse cardiovascular events (OR, 0.54; 95% CI, 0.32-0.91), cardiovascular mortality (OR, 0.43; 95% CI, 0.20-0.95), and heart failure readmissions (OR, 0.57; 95% CI, 0.36-0.89), favoring the patients in the CTO percutaneous coronary intervention group. No significant differences were observed between the 2 groups for all-cause mortality (OR, 0.47; 95% CI, 0.22-1.00), myocardial infarction (OR, 0.78; 95% CI, 0.41-1.46), repeat revascularization (OR, 1.13; 95% CI, 0.56-2.27), and stroke (OR, 0.51; 95% CI, 0.20-1.33). CONCLUSIONS: In this meta-analysis, CTO percutaneous coronary intervention of the noninfarct-related artery in patients presenting with ST-segment-elevation myocardial infarction was associated with a significant reduction in major adverse cardiovascular events, cardiovascular mortality, and heart failure readmissions.

Original languageEnglish (US)
JournalJournal of the American Heart Association
Volume7
Issue number8
DOIs
StatePublished - Apr 13 2018
Externally publishedYes

Fingerprint

Meta-Analysis
Odds Ratio
Confidence Intervals
Percutaneous Coronary Intervention
Mortality
Arteries
Heart Failure
Stroke
Myocardial Infarction
ST Elevation Myocardial Infarction
Coronary Artery Bypass
Databases

Keywords

  • chronic total occlusion
  • meta‐analysis
  • percutaneous coronary intervention
  • ST‐segment–elevation myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction : A Systematic Review and Meta-Analysis. / Villablanca, Pedro A.; Olmedo, Wilman; Weinreich, Michael; Gupta, Tanush; Mohananey, Divyanshu; Albuquerque, Felipe N.; Kassas, Ibrahim; Briceño, David; Sanina, Cristina; Brevik, Thomas A.; Ong, Emily; Ramakrishna, Harish; Attubato, Michael; Menegus, Mark; Wiley, Jose; Kalra, Ankur.

In: Journal of the American Heart Association, Vol. 7, No. 8, 13.04.2018.

Research output: Contribution to journalReview article

Villablanca, PA, Olmedo, W, Weinreich, M, Gupta, T, Mohananey, D, Albuquerque, FN, Kassas, I, Briceño, D, Sanina, C, Brevik, TA, Ong, E, Ramakrishna, H, Attubato, M, Menegus, M, Wiley, J & Kalra, A 2018, 'Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis', Journal of the American Heart Association, vol. 7, no. 8. https://doi.org/10.1161/JAHA.117.008415
Villablanca, Pedro A. ; Olmedo, Wilman ; Weinreich, Michael ; Gupta, Tanush ; Mohananey, Divyanshu ; Albuquerque, Felipe N. ; Kassas, Ibrahim ; Briceño, David ; Sanina, Cristina ; Brevik, Thomas A. ; Ong, Emily ; Ramakrishna, Harish ; Attubato, Michael ; Menegus, Mark ; Wiley, Jose ; Kalra, Ankur. / Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction : A Systematic Review and Meta-Analysis. In: Journal of the American Heart Association. 2018 ; Vol. 7, No. 8.
@article{2d4d282903b641f58926c7ea931add8b,
title = "Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis",
abstract = "BACKGROUND: Studies have shown that chronic total occlusion (CTO) in a noninfarct-related artery in patients with ST-segment-elevation myocardial infarction is linked to increased mortality. It remains unclear whether staged revascularization of a noninfarct-related artery CTO in patients with ST-segment-elevation myocardial infarction translates to improved outcomes. We performed a meta-analysis to compare outcomes between patients presenting with ST-segment-elevation myocardial infarction with concurrent CTO who underwent percutaneous coronary intervention of noninfarct-related artery CTO versus those who did not. METHOD AND RESULTS: We conducted an electronic database search of all published data. The primary end point was major adverse cardiovascular events. Secondary end points were all-cause mortality, cardiovascular mortality, myocardial infarction, repeat revascularization with either percutaneous coronary intervention or coronary artery bypass grafting, stroke, and heart failure readmission. Odds ratios (ORs) and 95{\%} confidence intervals (CIs) were computed. Random effects model was used and heterogeneity was considered if I2 >25. Six studies (n=1253 patients) were included in the analysis. There was a significant difference in major adverse cardiovascular events (OR, 0.54; 95{\%} CI, 0.32-0.91), cardiovascular mortality (OR, 0.43; 95{\%} CI, 0.20-0.95), and heart failure readmissions (OR, 0.57; 95{\%} CI, 0.36-0.89), favoring the patients in the CTO percutaneous coronary intervention group. No significant differences were observed between the 2 groups for all-cause mortality (OR, 0.47; 95{\%} CI, 0.22-1.00), myocardial infarction (OR, 0.78; 95{\%} CI, 0.41-1.46), repeat revascularization (OR, 1.13; 95{\%} CI, 0.56-2.27), and stroke (OR, 0.51; 95{\%} CI, 0.20-1.33). CONCLUSIONS: In this meta-analysis, CTO percutaneous coronary intervention of the noninfarct-related artery in patients presenting with ST-segment-elevation myocardial infarction was associated with a significant reduction in major adverse cardiovascular events, cardiovascular mortality, and heart failure readmissions.",
keywords = "chronic total occlusion, meta‐analysis, percutaneous coronary intervention, ST‐segment–elevation myocardial infarction",
author = "Villablanca, {Pedro A.} and Wilman Olmedo and Michael Weinreich and Tanush Gupta and Divyanshu Mohananey and Albuquerque, {Felipe N.} and Ibrahim Kassas and David Brice{\~n}o and Cristina Sanina and Brevik, {Thomas A.} and Emily Ong and Harish Ramakrishna and Michael Attubato and Mark Menegus and Jose Wiley and Ankur Kalra",
year = "2018",
month = "4",
day = "13",
doi = "10.1161/JAHA.117.008415",
language = "English (US)",
volume = "7",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction

T2 - A Systematic Review and Meta-Analysis

AU - Villablanca, Pedro A.

AU - Olmedo, Wilman

AU - Weinreich, Michael

AU - Gupta, Tanush

AU - Mohananey, Divyanshu

AU - Albuquerque, Felipe N.

AU - Kassas, Ibrahim

AU - Briceño, David

AU - Sanina, Cristina

AU - Brevik, Thomas A.

AU - Ong, Emily

AU - Ramakrishna, Harish

AU - Attubato, Michael

AU - Menegus, Mark

AU - Wiley, Jose

AU - Kalra, Ankur

PY - 2018/4/13

Y1 - 2018/4/13

N2 - BACKGROUND: Studies have shown that chronic total occlusion (CTO) in a noninfarct-related artery in patients with ST-segment-elevation myocardial infarction is linked to increased mortality. It remains unclear whether staged revascularization of a noninfarct-related artery CTO in patients with ST-segment-elevation myocardial infarction translates to improved outcomes. We performed a meta-analysis to compare outcomes between patients presenting with ST-segment-elevation myocardial infarction with concurrent CTO who underwent percutaneous coronary intervention of noninfarct-related artery CTO versus those who did not. METHOD AND RESULTS: We conducted an electronic database search of all published data. The primary end point was major adverse cardiovascular events. Secondary end points were all-cause mortality, cardiovascular mortality, myocardial infarction, repeat revascularization with either percutaneous coronary intervention or coronary artery bypass grafting, stroke, and heart failure readmission. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed. Random effects model was used and heterogeneity was considered if I2 >25. Six studies (n=1253 patients) were included in the analysis. There was a significant difference in major adverse cardiovascular events (OR, 0.54; 95% CI, 0.32-0.91), cardiovascular mortality (OR, 0.43; 95% CI, 0.20-0.95), and heart failure readmissions (OR, 0.57; 95% CI, 0.36-0.89), favoring the patients in the CTO percutaneous coronary intervention group. No significant differences were observed between the 2 groups for all-cause mortality (OR, 0.47; 95% CI, 0.22-1.00), myocardial infarction (OR, 0.78; 95% CI, 0.41-1.46), repeat revascularization (OR, 1.13; 95% CI, 0.56-2.27), and stroke (OR, 0.51; 95% CI, 0.20-1.33). CONCLUSIONS: In this meta-analysis, CTO percutaneous coronary intervention of the noninfarct-related artery in patients presenting with ST-segment-elevation myocardial infarction was associated with a significant reduction in major adverse cardiovascular events, cardiovascular mortality, and heart failure readmissions.

AB - BACKGROUND: Studies have shown that chronic total occlusion (CTO) in a noninfarct-related artery in patients with ST-segment-elevation myocardial infarction is linked to increased mortality. It remains unclear whether staged revascularization of a noninfarct-related artery CTO in patients with ST-segment-elevation myocardial infarction translates to improved outcomes. We performed a meta-analysis to compare outcomes between patients presenting with ST-segment-elevation myocardial infarction with concurrent CTO who underwent percutaneous coronary intervention of noninfarct-related artery CTO versus those who did not. METHOD AND RESULTS: We conducted an electronic database search of all published data. The primary end point was major adverse cardiovascular events. Secondary end points were all-cause mortality, cardiovascular mortality, myocardial infarction, repeat revascularization with either percutaneous coronary intervention or coronary artery bypass grafting, stroke, and heart failure readmission. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed. Random effects model was used and heterogeneity was considered if I2 >25. Six studies (n=1253 patients) were included in the analysis. There was a significant difference in major adverse cardiovascular events (OR, 0.54; 95% CI, 0.32-0.91), cardiovascular mortality (OR, 0.43; 95% CI, 0.20-0.95), and heart failure readmissions (OR, 0.57; 95% CI, 0.36-0.89), favoring the patients in the CTO percutaneous coronary intervention group. No significant differences were observed between the 2 groups for all-cause mortality (OR, 0.47; 95% CI, 0.22-1.00), myocardial infarction (OR, 0.78; 95% CI, 0.41-1.46), repeat revascularization (OR, 1.13; 95% CI, 0.56-2.27), and stroke (OR, 0.51; 95% CI, 0.20-1.33). CONCLUSIONS: In this meta-analysis, CTO percutaneous coronary intervention of the noninfarct-related artery in patients presenting with ST-segment-elevation myocardial infarction was associated with a significant reduction in major adverse cardiovascular events, cardiovascular mortality, and heart failure readmissions.

KW - chronic total occlusion

KW - meta‐analysis

KW - percutaneous coronary intervention

KW - ST‐segment–elevation myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=85048016379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048016379&partnerID=8YFLogxK

U2 - 10.1161/JAHA.117.008415

DO - 10.1161/JAHA.117.008415

M3 - Review article

C2 - 29654206

AN - SCOPUS:85048016379

VL - 7

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 8

ER -